Last updated on January 2020

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Vitamin Deficiency | Vitamin D Deficiency | Critical Illness
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • 18 years
  • Anticipated ICU stay 48 hours
  • Admission to ICU 72 hours before screening
  • Severe vitamin D deficiency (12 ng/ml or undetectable)

Exclusion Criteria:

  • Severe gastrointestinal dysfunction (> 400 ml residual volume)/unable to take study medication
  • Do not resuscitate (DNR) order/imminent death
  • hypercalcemia
  • known recent nephrolithiasis, active tuberculosis or sarcoidosis
  • pregnancy/lactation
  • not deemed appropriate by study team/physician

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.